Production (Stage)
Palisade Bio, Inc.
PALI
$0.6967
$0.01642.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.36M | 1.30M | 1.46M | 1.58M | 1.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.31M | 3.38M | 3.59M | 4.21M | 3.67M |
| Operating Income | -2.31M | -3.38M | -3.59M | -4.21M | -3.67M |
| Income Before Tax | -2.23M | -3.34M | -3.49M | -4.08M | -3.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.23M | -3.34M | -3.49M | -4.08M | -3.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.23M | -3.34M | -3.49M | -4.08M | -3.53M |
| EBIT | -2.31M | -3.38M | -3.59M | -4.21M | -3.67M |
| EBITDA | -2.31M | -3.38M | -3.59M | -4.21M | -3.67M |
| EPS Basic | -0.47 | -1.55 | -2.32 | -3.32 | -4.59 |
| Normalized Basic EPS | -0.29 | -0.97 | -1.45 | -2.08 | -2.87 |
| EPS Diluted | -0.47 | -1.55 | -2.32 | -3.32 | -4.59 |
| Normalized Diluted EPS | -0.29 | -0.97 | -1.45 | -2.08 | -2.87 |
| Average Basic Shares Outstanding | 4.80M | 2.16M | 1.50M | 1.23M | 768.10K |
| Average Diluted Shares Outstanding | 4.80M | 2.16M | 1.50M | 1.23M | 768.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |